| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $630.9M | -3.9% | +1.1% |
| Cost of Revenue | $303.7M | -6.6% | -0.8% |
| Gross Profit | $327.3M | -1.2% | +2.9% |
| R&D Expense | $58.8M | -9.5% | -1.3% |
| SG&A Expense | $110.4M | +7.3% | -27.1% |
| Operating Income | $52.5M | +467.1% | +262.0% |
| Pre-tax Income | $26.9M | +169.0% | +157.4% |
| Income Tax | $400K | +300.0% | -50.0% |
| Net Income | $26.4M | +168.0% | +155.3% |
| EPS (Basic) | $0.06 | +166.7% | +150.0% |
| EPS (Diluted) | $0.06 | +166.7% | +150.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.13B | -4.5% | +23.2% |
| Accounts Receivable | $78.6M | -16.9% | -16.0% |
| Inventory | $175.8M | -18.2% | -17.7% |
| Current Assets | $1.44B | -7.6% | +7.3% |
| Total Assets | $2.02B | -6.8% | -2.3% |
| Current Liabilities | $577.9M | -26.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $296.5M | — | — |
| Investing Cash Flow | -$9.8M | — | — |
| Financing Cash Flow | -$203.8M | — | — |
| -28.8% |
| Long-term Debt | $1.33B | -13.1% | -13.6% |
| Total Liabilities | $2.26B | -9.3% | -11.6% |
| Stockholders' Equity | -$241.9M | +26.0% | +50.8% |